AIM logo

AIM ImmunoTech (AIM) Total Liabilities

Annual Total Liabilities

$9.15 M
+$7.13 M+352.82%

31 December 2023

AIM Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Liabilities

$10.68 M
+$1.06 M+11.06%

30 September 2024

AIM Quarterly Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AIM Total Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+352.8%+103.0%
3 y3 years+178.0%+933.5%
5 y5 years+5.5%+23.5%

AIM Total Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+1015.5%-6.0%+1202.0%
5 y5 yearsat high+1015.5%-6.0%+1202.0%
alltimeall time-29.6%+1043.4%-17.9%+1234.5%

AIM ImmunoTech Total Liabilities History

DateAnnualQuarterly
Sept 2024
-
$10.68 M(+11.1%)
June 2024
-
$9.61 M(-15.4%)
Mar 2024
-
$11.36 M(+24.2%)
Dec 2023
$9.15 M(+352.8%)
$9.15 M(+73.9%)
Sept 2023
-
$5.26 M(+51.0%)
June 2023
-
$3.48 M(+40.8%)
Mar 2023
-
$2.47 M(+22.4%)
Dec 2022
$2.02 M(+146.3%)
$2.02 M(-43.7%)
Sept 2022
-
$3.59 M(+70.6%)
June 2022
-
$2.10 M(+146.4%)
Mar 2022
-
$854.00 K(+4.1%)
Dec 2021
$820.00 K(-75.1%)
$820.00 K(-20.6%)
Sept 2021
-
$1.03 M(-13.2%)
June 2021
-
$1.19 M(-61.9%)
Mar 2021
-
$3.12 M(-5.1%)
Dec 2020
$3.29 M(-55.0%)
$3.29 M(+7.8%)
Sept 2020
-
$3.05 M(-2.5%)
June 2020
-
$3.13 M(-57.1%)
Mar 2020
-
$7.30 M(-0.2%)
Dec 2019
$7.31 M(-15.7%)
$7.31 M(-15.4%)
Sept 2019
-
$8.65 M(+19.1%)
June 2019
-
$7.26 M(-39.7%)
Mar 2019
-
$12.04 M(+38.8%)
Dec 2018
$8.67 M(+57.5%)
$8.67 M(-0.7%)
Sept 2018
-
$8.73 M(+32.5%)
June 2018
-
$6.59 M(+8.7%)
Mar 2018
-
$6.06 M(+10.1%)
Dec 2017
$5.50 M(+63.1%)
$5.50 M(+17.5%)
Sept 2017
-
$4.68 M(-18.9%)
June 2017
-
$5.78 M(+47.5%)
Mar 2017
-
$3.92 M(+16.0%)
Dec 2016
$3.38 M(+38.7%)
$3.38 M(-31.7%)
Sept 2016
-
$4.95 M(+11.7%)
June 2016
-
$4.43 M(+43.2%)
Mar 2016
-
$3.09 M(+27.1%)
Dec 2015
$2.43 M(-45.2%)
$2.43 M(-26.9%)
Sept 2015
-
$3.33 M(+7.3%)
June 2015
-
$3.10 M(-18.8%)
Mar 2015
-
$3.82 M(-13.9%)
Dec 2014
$4.44 M(+72.7%)
$4.44 M(+3.8%)
Sept 2014
-
$4.27 M(+2.2%)
June 2014
-
$4.18 M(+38.6%)
Mar 2014
-
$3.02 M(+17.4%)
Dec 2013
$2.57 M(-80.2%)
$2.57 M(-76.1%)
Sept 2013
-
$10.73 M(+7.3%)
June 2013
-
$10.00 M(-2.7%)
Mar 2013
-
$10.28 M(-20.9%)
Dec 2012
$13.00 M(+134.3%)
$13.00 M(+8.6%)
Sept 2012
-
$11.97 M(+58.0%)
June 2012
-
$7.58 M(+14.8%)
Mar 2012
-
$6.60 M(+18.9%)
Dec 2011
$5.55 M(-3.2%)
$5.55 M(+11.8%)
Sept 2011
-
$4.96 M(+26.2%)
June 2011
-
$3.93 M(-31.4%)
Mar 2011
-
$5.73 M(0.0%)
Dec 2010
$5.73 M
$5.73 M(+131.7%)
Sept 2010
-
$2.47 M(+30.2%)
June 2010
-
$1.90 M(-23.6%)
DateAnnualQuarterly
Mar 2010
-
$2.49 M(-60.5%)
Dec 2009
$6.30 M(+277.9%)
$6.30 M(+354.8%)
Sept 2009
-
$1.39 M(-45.4%)
June 2009
-
$2.54 M(+3.6%)
Mar 2009
-
$2.45 M(+46.8%)
Dec 2008
$1.67 M(-23.8%)
$1.67 M(-22.9%)
Sept 2008
-
$2.16 M(+11.7%)
June 2008
-
$1.94 M(-12.2%)
Mar 2008
-
$2.21 M(+0.8%)
Dec 2007
$2.19 M(-67.3%)
$2.19 M(-17.9%)
Sept 2007
-
$2.66 M(-6.8%)
June 2007
-
$2.86 M(-58.7%)
Mar 2007
-
$6.91 M(+3.5%)
Dec 2006
$6.68 M(+10.8%)
$6.68 M(-7.4%)
Sept 2006
-
$7.22 M(+6.6%)
June 2006
-
$6.77 M(+15.2%)
Mar 2006
-
$5.88 M(-2.4%)
Dec 2005
$6.03 M(+61.5%)
$6.03 M(+5.1%)
Sept 2005
-
$5.74 M(+1.1%)
June 2005
-
$5.67 M(+7.1%)
Mar 2005
-
$5.30 M(+42.0%)
Dec 2004
$3.73 M(-10.2%)
$3.73 M(-18.8%)
Sept 2004
-
$4.60 M(-6.0%)
June 2004
-
$4.89 M(-37.0%)
Mar 2004
-
$7.76 M(+86.8%)
Dec 2003
$4.16 M(+183.9%)
$4.16 M(-10.3%)
Sept 2003
-
$4.63 M(+171.8%)
June 2003
-
$1.70 M(-58.7%)
Mar 2003
-
$4.13 M(+181.8%)
Dec 2002
$1.46 M(+15.1%)
$1.46 M(+56.7%)
Sept 2002
-
$934.00 K(+14.2%)
June 2002
-
$818.00 K(-39.4%)
Mar 2002
-
$1.35 M(+6.1%)
Dec 2001
$1.27 M(-14.9%)
$1.27 M(+1.8%)
Sept 2001
-
$1.25 M(+11.3%)
June 2001
-
$1.12 M(-9.4%)
Mar 2001
-
$1.24 M(-17.1%)
Dec 2000
$1.50 M(+1.8%)
$1.50 M(+65.5%)
Sept 2000
-
$903.40 K(-27.4%)
June 2000
-
$1.25 M(+5.4%)
Mar 2000
-
$1.18 M(-19.5%)
Dec 1999
$1.47 M(+33.5%)
$1.47 M(-30.1%)
Sept 1999
-
$2.10 M(-4.5%)
June 1999
-
$2.20 M(+29.4%)
Mar 1999
-
$1.70 M(+54.5%)
Dec 1998
$1.10 M(+37.5%)
$1.10 M(+22.2%)
Sept 1998
-
$900.00 K(-10.0%)
June 1998
-
$1.00 M(+25.0%)
Mar 1998
-
$800.00 K(0.0%)
Dec 1997
$800.00 K(-27.3%)
$800.00 K(-42.9%)
Sept 1997
-
$1.40 M(+55.6%)
June 1997
-
$900.00 K(-10.0%)
Mar 1997
-
$1.00 M(-9.1%)
Dec 1996
$1.10 M(-86.7%)
$1.10 M(0.0%)
Sept 1996
-
$1.10 M(-31.3%)
June 1996
-
$1.60 M(+14.3%)
Mar 1996
-
$1.40 M(-83.1%)
Dec 1995
$8.30 M
$8.30 M

FAQ

  • What is AIM ImmunoTech annual total liabilities?
  • What is the all time high annual total liabilities for AIM ImmunoTech?
  • What is AIM ImmunoTech annual total liabilities year-on-year change?
  • What is AIM ImmunoTech quarterly total liabilities?
  • What is the all time high quarterly total liabilities for AIM ImmunoTech?
  • What is AIM ImmunoTech quarterly total liabilities year-on-year change?

What is AIM ImmunoTech annual total liabilities?

The current annual total liabilities of AIM is $9.15 M

What is the all time high annual total liabilities for AIM ImmunoTech?

AIM ImmunoTech all-time high annual total liabilities is $13.00 M

What is AIM ImmunoTech annual total liabilities year-on-year change?

Over the past year, AIM annual total liabilities has changed by +$7.13 M (+352.82%)

What is AIM ImmunoTech quarterly total liabilities?

The current quarterly total liabilities of AIM is $10.68 M

What is the all time high quarterly total liabilities for AIM ImmunoTech?

AIM ImmunoTech all-time high quarterly total liabilities is $13.00 M

What is AIM ImmunoTech quarterly total liabilities year-on-year change?

Over the past year, AIM quarterly total liabilities has changed by +$5.42 M (+103.00%)